In pancreatic cancer, loss of E-cadherin expression is associated with high grade and advanced stage (Pignatelli et al, 1994; Karayiannakis et al, 1998), and is a marker of poor prognosis (Kuniyasu et al, 1999). Here, CDH1 is linked to pancreatic neoplasm.